Verified peer comparison
GT Biopharma vs Decent Holding Financial Comparison
Direct answer
GT Biopharma and Decent Holding are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- GT Biopharma Revenue
- 0 USD
- Decent Holding Revenue
- 12,949,345 USD
- GT Biopharma Operating income
- -12,422,000 USD
- Decent Holding Operating income
- -138,576 USD